The effect of favipiravir versus hydroxychloroquine on clinical and laboratory findings in COVID-19 in healthcare workers
Derya Turan, Mehtap Menteş, Yıldıran Özel, Kıvanç Şerefhanoğlu et autres
OBJECTIVES: Comparative data on hydroxychloroquine and favipiravir, commonly used agents in the treatment of Coronavirus Disease-2019 (COVID-19), are still limited. In this study, it was aimed to compare treatment outcomes in healthcare workers with COVID-19 who were prospectively followed by the occupational …
tr (code pays fourni par la source)
1 citation
The Brazilian Journal of Infectious Diseases